Salbutamol Completed Phase 1 Trials for Congenital Myasthenic Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01203592Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes